Affiliation:
1. Moscow Regional Research and Clinical Institute
Abstract
Vascular access is the cornerstone of hemodialysis. With vascular access dysfunction, the results of treatment of patients with stage 5 chronic kidney disease significantly deteriorate. One of the most common causes of vascular access failure is peripheral venous stenosis. Despite the variety of initiating factors, the morphological substrate of stenotic damage to the arteriovenous fistula (or arteriovenous anastomosis) in most cases is neointimal hyperplasia. Stenotic lesions of the arterivenous fistula are strongly associated with an increased risk of thrombosis and loss of vascular access. There are 4 typical localizations of stenosis: arteriovenous or arteriograft anastomosis, stenosis of the juxta-anastomotic segment of the fistula, stenosis of the functional segment of the fistula, and stenosis of the cephalic arc.The most common indication for surgical treatment is vascular access failure; less common indications are clinical symptoms of venous insufficiency.There are various methods of open reconstruction of the stenotic segment of the fistula vein: resection, prosthetics with a synthetic vascular graft, prosthetics or plastic repair of the autologous vein wall, complete or partial drainage of the prestenotic segment of the vein, etc. Currently an alternative method of stenosis repair using endovascular interventions is gaining popularity. In contrast to central vein stenosis, where endovascular interventions are the gold standard, in peripheral vein stenosis it is only an adjuvant method. Complications of endovascular interventions are extremely rare.Despite the fact that endovascular interventions have almost absolute probability of technical success, the primary patency is not high and is about 50% in six months. The use of bare stents is not accompanied by an increase in primary patency. The use of stent-grafts can increase the primary patency, especially in the plastic repair of challenging stenoses of the graft-vein anastomosis or cephalic arch.Many issues related to endovascular interventions remain unresolved, which requires further research.
Publisher
Siberian State Medical University
Reference74 articles.
1. European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015. 2017. URL: https://www.era-edta-reg.org/files/annualreports/pdf/AnnRep2015.pdf
2. United States Renal Data System. 2016 USRDS annual data report. Vol. 2 – End-stage Renal Disease (ESRD) in the United States: 1 Incidence, Prevalence, Patient Characteristics, and Treatment Modalities 2016. URL: https:// www.usrds.org/2016/view/Default.aspx
3. Tomilina N.A., Andrusev A.M., Peregudova N.G., Shinkarev M.B. Renal replacement therapy for End Stage Renal Disease in the Russian Federation, 2010–2015. Russian National Renal Replacement Therapy Registry Report of Russian Public Organization of Nephrologists “Russian Dialysis Society”, Pt 1. Nephrology and Dialysis. 2017; 19 (4, Suppl.): 1–95. (in Russ.). DOI: 10.28996/1680-4422-2017-4suppl-1-95.
4. Mickley V. Central vein obstruction in vascular access. Eur. J. Vasc. Endovasc. Surg. 2006; 32 (4): 439–444.
5. Pirozzi N., Garcia-Medina J., Hanoy M. Stenosis complicating vascular access for hemodialysis: indications for treatment. J. Vasc. Access. 2014; 15 (2): 76–82. DOI: 10.5301/jva.5000194.